{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:18:30Z","timestamp":1790147910629,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["AAP-2012-032"],"award-info":[{"award-number":["AAP-2012-032"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-COHO-0006"],"award-info":[{"award-number":["ANR-10-COHO-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008018","name":"Mutuelle G\u00e9n\u00e9rale de l'Education Nationale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008017","name":"Institut Gustave-Roussy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00228-018-2515-4","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T22:29:37Z","timestamp":1530656977000},"page":"1475-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50\u00a0years"],"prefix":"10.1007","volume":"74","author":[{"given":"Sylvie","family":"Mesrine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Gusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Clavel-Chapelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Boutron-Ruault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-3439","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"2515_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry 72:136\u2013142. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1763","journal-title":"JAMA Psychiatry"},{"key":"2515_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/HCO.0000000000000324","volume":"31","author":"MA Grandner","year":"2016","unstructured":"Grandner MA, Alfonso-Miller P, Fernandez-Mendoza J, Shetty S, Shenoy S, Combs D (2016) Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol 31:551\u2013565. https:\/\/doi.org\/10.1097\/HCO.0000000000000324","journal-title":"Curr Opin Cardiol"},{"key":"2515_CR3","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, L\u00f8chen ML, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp H, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37:2315\u20132381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106","journal-title":"Eur Heart J"},{"key":"2515_CR4","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.jacc.2018.03.458","volume":"71","author":"IL Pi\u00f1a","year":"2018","unstructured":"Pi\u00f1a IL, Di Palo KE, Ventura HO (2018) Psychopharmacology and cardiovascular disease. J Am Coll Cardiol 71:2346\u20132359. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.458","journal-title":"J Am Coll Cardiol"},{"key":"2515_CR5","first-page":"CD009622","volume":"10","author":"J Liu","year":"2016","unstructured":"Liu J, Wang LN, Ma X, Ji X (2016) Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev 10:CD009622","journal-title":"Cochrane Database Syst Rev"},{"key":"2515_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/02699052.2017.1300836","volume":"31","author":"JA Sutton","year":"2017","unstructured":"Sutton JA, Clauss RP (2017) A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: a justification of further clinical trials. Brain Inj 31:1019\u20131027. https:\/\/doi.org\/10.1080\/02699052.2017.1300836","journal-title":"Brain Inj"},{"issue":"8","key":"2515_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00228-018-2466-9","volume":"74","author":"Daniele Bosone","year":"2018","unstructured":"Bosone D, Fogari R, Zoppi A, D'Angelo A, Ghiotto N, Perini G, Ramusino MC, Costa A (2018) Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-018-2466-9","journal-title":"European Journal of Clinical Pharmacology"},{"key":"2515_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ajh\/hpx188","volume":"31","author":"N Mendelson","year":"2018","unstructured":"Mendelson N, Gontmacher B, Vodonos A, Novack V, Abu-AjAj M, Wolak A, Shalev H, Wolak T (2018) Benzodiazepine consumption is associated with lower blood pressure in ambulatory blood pressure monitoring (ABPM): retrospective analysis of 4938 ABPMs. Am J Hypertens 31:431\u2013437. https:\/\/doi.org\/10.1093\/ajh\/hpx188","journal-title":"Am J Hypertens"},{"key":"2515_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0004867415616695","volume":"50","author":"AK Parsaik","year":"2016","unstructured":"Parsaik AK, Mascarenhas SS, Khosh-Chashm D, Hashmi A, John V, Okusaga O, Singh B (2016) Mortality associated with anxiolytic and hypnotic drugs\u2014a systematic review and meta-analysis. Aust N Z J Psychiatry 50:520\u2013533. https:\/\/doi.org\/10.1177\/0004867415616695","journal-title":"Aust N Z J Psychiatry"},{"key":"2515_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/10.1016\/j.atherosclerosis.2014.05.918","volume":"235","author":"CK Wu","year":"2014","unstructured":"Wu CK, Huang YT, Lee JK, Jimmy Juang JM, Tsai CT, Lai LP, Hwang JJ, Chiang FT, Lin JL, Chen PC, Lin LY (2014) Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis 235:496\u2013502. https:\/\/doi.org\/10.1016\/10.1016\/j.atherosclerosis.2014.05.918","journal-title":"Atherosclerosis"},{"key":"2515_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145271","volume":"10","author":"TY Lan","year":"2015","unstructured":"Lan TY, Zeng YF, Tang GJ, Kao HC, Chiu HJ, Lan TH, Ho HF (2015) The use of hypnotics and mortality\u2014a population-based retrospective cohort study. PLoS One 10:e0145271. https:\/\/doi.org\/10.1371\/journal.pone.0145271","journal-title":"PLoS One"},{"key":"2515_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/eurheartj\/ehr368","volume":"33","author":"J Honkola","year":"2012","unstructured":"Honkola J, Hookana E, Malinen S, Kaikkonen KS, Junttila MJ, Isohanni M, Kortelainen ML, Huikuri HV (2012) Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J 33:745\u2013751. https:\/\/doi.org\/10.1093\/eurheartj\/ehr368","journal-title":"Eur Heart J"},{"key":"2515_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.5665\/sleep.2884","volume":"36","author":"HC Chen","year":"2013","unstructured":"Chen HC, Su TP, Chou P (2013) A nine-year follow-up study of sleep patterns and mortality in community-dwelling older adults in Taiwan. Sleep 36:1187\u20131198. https:\/\/doi.org\/10.5665\/sleep.2884","journal-title":"Sleep"},{"key":"2515_CR14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ijcard.2012.03.143","volume":"167","author":"C Diez-Quevedo","year":"2013","unstructured":"Diez-Quevedo C, Lupon J, Gonzalez B et al (2013) Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol 167:1217\u20131225. https:\/\/doi.org\/10.1016\/j.ijcard.2012.03.143","journal-title":"Int J Cardiol"},{"key":"2515_CR15","doi-asserted-by":"publisher","unstructured":"Jaussent I, Ancelin ML, Berr C, P\u00e9r\u00e8s K, Scali J, Besset A, Ritchie K, Dauvilliers Y (2013) Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med 11(212). https:\/\/doi.org\/10.1186\/1741-7015-11-212","DOI":"10.1186\/1741-7015-11-212"},{"key":"2515_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/0140-6736(92)93081-W","volume":"340","author":"M Thorogood","year":"1992","unstructured":"Thorogood M, Cowen P, Mann J, Murphy M, Vessey M (1992) Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet 340:1067\u20131068","journal-title":"Lancet"},{"key":"2515_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.sleep.2008.12.004","volume":"10","author":"L Mallon","year":"2009","unstructured":"Mallon L, Broman JE, Hetta J (2009) Is usage of hypnotics associated with mortality? Sleep Med 10:279\u2013286. https:\/\/doi.org\/10.1016\/j.sleep.2008.12.004","journal-title":"Sleep Med"},{"key":"2515_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/aje\/kwq371","volume":"173","author":"NH Rod","year":"2011","unstructured":"Rod NH, Vahtera J, Westerlund H, Kivimaki M, Zins M, Goldberg M, Lange T (2011) Sleep disturbances and cause-specific mortality: results from the GAZEL cohort study. Am J Epidemiol 173:300\u2013309. https:\/\/doi.org\/10.1093\/aje\/kwq371","journal-title":"Am J Epidemiol"},{"key":"2515_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","volume":"173","author":"J Tiihonen","year":"2016","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, Tanskanen A (2016) Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study. Am J Psychiatry 173:600\u2013606. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15050618","journal-title":"Am J Psychiatry"},{"key":"2515_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00228-015-1841-z","volume":"71","author":"CI Neutel","year":"2015","unstructured":"Neutel CI, Johansen HL (2015) Association between hypnotics use and increased mortality: causation or confounding? Eur J Clin Pharmacol 71:637\u2013642. https:\/\/doi.org\/10.1007\/s00228-015-1841-z","journal-title":"Eur J Clin Pharmacol"},{"key":"2515_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/SPC.0000000000000188","volume":"10","author":"PM Davidson","year":"2016","unstructured":"Davidson PM, Phillips JL, Dennison-Himmelfarb C, Thompson SC, Luckett T, Currow DC (2016) Providing palliative care for cardiovascular disease from a perspective of sociocultural diversity: a global view. Curr Opin Support Palliat Care 10:11\u201317. https:\/\/doi.org\/10.1097\/SPC.0000000000000188","journal-title":"Curr Opin Support Palliat Care"},{"key":"2515_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0006-8993(83)91162-9","volume":"258","author":"PT Kelly","year":"1983","unstructured":"Kelly PT, McCulloch J (1983) The effects of the GABAergic agonist muscimol upon the relationship between local cerebral blood flow and glucose utilization. Brain Res 258:338\u2013342","journal-title":"Brain Res"},{"key":"2515_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jns.2010.10.024","volume":"301","author":"OZ Chi","year":"2011","unstructured":"Chi OZ, Hunter C, Liu X, Chi Y, Weiss HR (2011) Effects of GABA(a) receptor blockade on regional cerebral blood flow and blood\u2013brain barrier disruption in focal cerebral ischemia. J Neurol Sci 301:66\u201370. https:\/\/doi.org\/10.1016\/j.jns.2010.10.024","journal-title":"J Neurol Sci"},{"key":"2515_CR24","volume-title":"Investigating the role of benzodiazepines in drug-related mortality\u2014a systematic review undertaken on behalf of the Scottish National Forum on drug-related deaths","author":"CF Johnson","year":"2016","unstructured":"Johnson CF, Barnsdale LR, McAuley A (2016) Investigating the role of benzodiazepines in drug-related mortality\u2014a systematic review undertaken on behalf of the Scottish National Forum on drug-related deaths. NHS Health Scotland, Edinburgh"},{"key":"2515_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ije\/dyu184","volume":"44","author":"Clavel-Chapelon F, E3N Study Group","year":"2015","unstructured":"Clavel-Chapelon F, E3N Study Group (2015) Cohort profile: the French E3N cohort study. Int J Epidemiol 44:801\u2013809. https:\/\/doi.org\/10.1093\/ije\/dyu184 Questionnaires available at http:\/\/www.e3n.fr\/index.php\/l-etude-e3n\/les-donnees","journal-title":"Int J Epidemiol"},{"key":"2515_CR26","doi-asserted-by":"publisher","unstructured":"Lamarche-Vadel A, Pavillon G, Aouba A, Johansson LA, Meyer L, Jougla E, Rey G (2014) Automated comparison of last hospital main diagnosis and underlying cause of death ICD10 codes, France, 2008\u22122009. BMC Med Inform Decis Mak 14(44). https:\/\/doi.org\/10.1186\/1472-6947-14-44","DOI":"10.1186\/1472-6947-14-44"},{"key":"2515_CR27","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology: DDD: definition and general considerations. http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ . Accessed November 23, 2017"},{"key":"2515_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0767399X00001590","volume":"4","author":"R Fuhrer","year":"1989","unstructured":"Fuhrer R, Rouillon F (1989) The French version of the Center for Epidemiologic Studies\u2013Depression Scale [in French]. Psychiatr Psychobiol 4:163\u2013166","journal-title":"Psychiatr Psychobiol"},{"key":"2515_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/aje\/kwn135","volume":"168","author":"S Suissa","year":"2008","unstructured":"Suissa S (2008) Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol 168:329\u2013335. https:\/\/doi.org\/10.1093\/aje\/kwn135","journal-title":"Am J Epidemiol"},{"key":"2515_CR30","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (2013) \u00c9tat des lieux de la consommation des benzodiaz\u00e9pines en France. http:\/\/ansm.sante.fr\/content\/download\/57511\/738785\/version\/2\/file\/ANSM_Rapport+Benzo_09012014.pdf . Accessed November 23, 2017"},{"key":"2515_CR31","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0140-6736(15)60171-4","volume":"386","author":"L Mikkelsen","year":"2015","unstructured":"Mikkelsen L, Phillips DE, AbouZahr C, Setel PW, de Savigny D, Lozano R, Lopez AD (2015) A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet 386:1395\u20131406. https:\/\/doi.org\/10.1016\/S0140-6736(15)60171-4","journal-title":"Lancet"},{"key":"2515_CR32","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1001\/archinternmed.2009.436","volume":"169","author":"JW Smoller","year":"2009","unstructured":"Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, Rosal MC, Wenger NK, Wassertheil-Smoller S (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women\u2019s Health Initiative study. Arch Intern Med 169:2128\u20132139. https:\/\/doi.org\/10.1001\/archinternmed.2009.436","journal-title":"Arch Intern Med"},{"key":"2515_CR33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jacc.2008.10.060","volume":"53","author":"W Whang","year":"2009","unstructured":"Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM (2009) Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses\u2019 Health Study. J Am Coll Cardiol 53:950\u2013958. https:\/\/doi.org\/10.1016\/j.jacc.2008.10.060","journal-title":"J Am Coll Cardiol"},{"key":"2515_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00228-016-2187-x","volume":"73","author":"A Biffi","year":"2017","unstructured":"Biffi A, Scotti L, Corrao G (2017) Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies. Eur J Clin Pharmacol 73:487\u2013497. https:\/\/doi.org\/10.1007\/s00228-016-2187-x","journal-title":"Eur J Clin Pharmacol"},{"key":"2515_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1017\/S1041610217002290","volume":"30","author":"A Hiance-Delahaye","year":"2017","unstructured":"Hiance-Delahaye A, de Schongor FM, Lechowski L, Teillet L, Arvieu JJ, Robine JM, Ankri J, Herr M (2017) Potentially inappropriate prescription of antidepressants in old people: characteristics, associated factors, and impact on mortality. Int Psychogeriatr 30:715\u2013726. https:\/\/doi.org\/10.1017\/S1041610217002290","journal-title":"Int Psychogeriatr"},{"key":"2515_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL (2016) Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013. Am J Public Health 106:686\u2013688. https:\/\/doi.org\/10.2105\/AJPH.2016.303061","journal-title":"Am J Public Health"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2515-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T01:43:15Z","timestamp":1604540595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2515"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2515-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}